PERRY CHRISTOPHER JOHN 4: 1,000 shares of VRSK ($180,000)

Our Take

→Perry's $180K purchase represents less than 1% of his existing holdings, a routine rebalancing move rather than a confidence signal. More telling is the timing: Verisk has spent the past two years pivoting from legacy insurance analytics toward AI-powered risk assessment, a transition that typically triggers insider selling during execution risk. Instead, Perry is buying into the narrative, suggesting the company's newer revenue streams—particularly in specialty insurance and parametric risk models—are gaining traction with the investor base who would know best.